Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### International Trade Administration

          - [A-588-878]

# AGENCY:

Enforcement and Compliance, International Trade Administration, Department of Commerce.

# SUMMARY:

The U.S. Department of Commerce (Commerce) is issuing these amended final results pursuant to a settlement agreement with Nagase & Co., Ltd. (Nagase) with respect to the final results of the administrative review of glycine from Japan during the period of review (POR) October 31, 2018, through May 31, 2020.

# DATES:

Applicable February 11, 2025.

# FOR FURTHER INFORMATION CONTACT:

John K. Drury, AD/CVD Operations, Office VI, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482-0195.

# SUPPLEMENTARY INFORMATION:

## Background

                    On September 29, 2021, Commerce published the final results of the 2018-2020 administrative review of the antidumping duty (AD) order on glycine from Japan.[1]                                          In the                     *Final Results,*                     Commerce calculated a weighted-average dumping margin of 27.71 percent for Nagase for the POR.[2] 

                    Following the publication of the                     *Final Results,*                     Nagase filed a lawsuit with the U.S. Court of International Trade (CIT) challenging certain aspects of Commerce's                     *Final Results,*                     including: (1) Commerce's inclusion of certain research and development (R&D) expenses unrelated to Nagase's costs of producing glycine; (2) Commerce's inclusion of compensation for payment expenses; and (3) Commerce's refusal to modify the importer-specific AD assessment rate calculated for Nagase's affiliated importer. On April 11, 2023, the CIT sustained, in part, and remanded, in part, Commerce's final results.[3]                                          Commerce filed its remand redetermination on August 9, 2023. In its remand redetermination, Commerce modified its treatment of the R&D expenses at issue and made no changes to its calculation methodology of the importer-specific AD assessment rate for Nagase's affiliated importer.[4]                                          The CIT sustained Commerce's redetermination on July 30, 2024.[5]                                          On October 2, 2024, Nagase appealed the decision to the U.S. Court of Appeals for the Federal Circuit (Federal Circuit).                

                    On January 30, 2025, the United States and Nagase entered into an agreement to settle this dispute. Pursuant to the terms of settlement, the parties have agreed to a final assessment as discussed below. The Federal Circuit issued its order dismissing the appeal on February 3, 2025.[6] 

## Assessment Rates

                    Consistent with the settlement agreement and the order of dismissal, issued on February 3, 2025, Commerce will instruct U.S. Customs and Border Protection (CBP) to liquidate all unliquidated entries produced by Yuki Gosei Kogyo Co., Ltd., exported by Nagase, and imported by Nagase America LLC or Nagase America Corporation at the rate at which cash deposits were collected at the time of entry during the 2018-2020 period of review and otherwise to liquidate entries of glycine produced by Yuki Gosei Kogyo Co., Ltd., exported by Yuki Gosei Kogyo Co., Ltd. or Nagase, and imported by an unaffiliated importer (                    *i.e.,*                     an importer other than Nagase America LLC or Nagase America Corporation) at the importer-specific assessment rate determined by Commerce in the                     *Final Results.*

                    Pursuant to section 751(a)(2)(C) of the Tariff Act of 1930, as amended (the Act), and 19 CFR 351.212(b)(1), Commerce has determined, and CBP shall assess, antidumping duties on all appropriate                           ( print page 9321)                        entries of subject merchandise in accordance with these revised final results of review.                

## Cash Deposit Requirements

                    Because Nagase has a superseding cash deposit rate,                     *i.e.,*                     there have been final results published in a subsequent administrative review, we are not revising the cash deposit rate and will not issue revised cash deposit instructions to CBP.                

## Notification to Interested Parties

We are issuing this determination and publishing these amended final results and notice in accordance with section 516(a)(e) of the Act.

Dated: February 5, 2025.

Abdelali Elouaradia,

Deputy Assistant Secretary for Enforcement and Compliance.

# Footnotes

1.                                                     *See Glycine from Japan: Final Results of Antidumping Duty Administrative Review; 2018-2020,*86 FR 53946 (September 29, 2021), and accompanying Issues and Decision Memorandum (IDM); and                         *Glycine from Japan: Final Results of Administrative Review; 2018-2020; Correction,*86 FR 57127 (October 14, 2021) (collectively,                         *Final Results*).                    
        Back to Citation      

2.                                                     *Id.*
        Back to Citation      

3.                                                     *See Nagase & Co.*                         v.                         *US,*                         628 F.Supp.3d 1326 (CIT 2023).                    
        Back to Citation      

4.                                                     *See Final Results of Redetermination Pursuant to Court Remand, Nagase & Co.*                         v.                         *US,*                         Court No. 21-00574, Slip Op. 23-46 (CIT April 11, 2023), dated August 8, 2023, available at                         *https://access.trade.gov/​public/​FinalRemandRedetermination.aspx.*
        Back to Citation      

5.                                                     *See Nagase & Co., Ltd.*                         v.                         *US,*                         719 F.Supp.3d 1343 (CIT 2024).                    
        Back to Citation      

6.                                                     *See Nagase & Co., Ltd.*                         v.                         *US,*                         CAFC 2025-1008, ECF No. 22, Order of Dismissal (February 3, 2025).                    
        Back to Citation      

[FR Doc. 2025-02458 Filed 2-10-25; 8:45 am]

BILLING CODE 3510-DS-P